Allosteric modulation of ligand binding to [ 3H](+)pentazocine-defined σ recognition sites by phenytoin

The allosteric modulation of σ recognition sites by phenytoin (diphenylhydantoin) has been demonstrated by the ability of phenytoin to stimulate binding of various [ 3H]σ ligands, as well as to slow dissociation from σ sites and to shift σ sites from a low- to a high-affinity state. Phenytoin stimul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 1993, Vol.53 (1), p.41-48
Hauptverfasser: DeHaven-Hudkins, D.L., Ford-Rice, F.Y., Allen, J.T., Hudkins, R.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The allosteric modulation of σ recognition sites by phenytoin (diphenylhydantoin) has been demonstrated by the ability of phenytoin to stimulate binding of various [ 3H]σ ligands, as well as to slow dissociation from σ sites and to shift σ sites from a low- to a high-affinity state. Phenytoin stimulated the binding of the σ 1-selective ligand [ 3H](+)pentazocine in a dose-dependent manner. Stimulation of binding at a final concentration of 250 μM phenytoin was associated with a decrease in the K D. The affinities of the σ reference compounds caramiphen, dextromethorphan, dextrorphan, (+)3-PPP and (+)SKF-10.047 were three- to eight-fold higher, while the affinities of benzetimide, BMY-14802, carbetapentane, DTG and haloperidol were unchanged in the presence of 250 μM phenytoin. The relative sensitivity of σ compounds to allosteric modulation by phenytoin is not a property of all σ ligands, and may provide an in vitro basis for distinguishing actions of σ compounds and predicting σ effects in vivo.
ISSN:0024-3205
1879-0631
DOI:10.1016/0024-3205(93)90609-7